NHS Set to Save Millions on Essential Prescribing Software through New Framework

NHS Shared Business ServicesThe NHS will have the opportunity to save millions of pounds on important but traditionally costly IT prescribing systems that help healthcare professionals to choose the correct and most cost effective medicines for patients, following the launch of a new procurement framework from NHS Shared Business Services (NHS SBS).

The new Medicines Management Prescribing Decision Support Systems Framework (MMDSS) is injecting healthy new competition into the market for the widely-used technology. The prescribing systems help doctors, nurses and other clinical staff select the most affordable and appropriate treatments for specific patients. NHS organisations can now choose to purchase either OptimiseRx or ScriptSwitch, without the need to engage in complex and costly individual procurement exercises.

The technology, which is particularly important for patient safety, is now being made available at more competitive rates and with improved contract terms through the shared services framework. The new MMDSS framework was created after five clinical commissioning groups (CCGs) turned to NHS SBS to allow them to approach the market for a more competitive service.

Each CCG from the collaborative across Central London, West London, Hammersmith and Fulham, Hounslow and Ealing, has now secured robust new terms and conditions with their chosen supplier as a result of the procurement work carried out by NHS SBS. This has helped the CCGs negotiate lower prices, without the need to work through the complexities of European procurement regulations, which NHS SBS has completed on their behalf. The result is a saving on software licenses of more than £60,000 per year for the CCGs.

These benefits could now spread quickly across the NHS, as a result of the MMDSS framework that was created by NHS SBS in parallel to the CCG procurements. This means that all NHS prescribing organisations now have a choice of competitive supplier and NHS favourable terms, without the need to run their own individual costly procurement exercises.

Thomas Slater, strategic procurement team, NHS Shared Business Services, said: "This is a great example of a real NHS collaboration that will help the wider NHS make significant savings on an important technology needed across the country.

"The five CCGs we have worked with are already reaping the benefits of supplier choice. Now the newly launched Medicines Management Prescribing Decision Support Systems Framework will allow the wider NHS to achieve better prices, terms and greater choice from the market in the same way, without the need to conduct their own time consuming and expensive competitions."

Following a robust selection process led by clinical, prescribing and pharmaceutical specialists, NHS organisations are now able to choose to purchase OptimiseRx, supplied by First Databank Europe Ltd, or ScriptSwitch, supplied by Optum Health Solutions, through the framework, without the need to navigate OJEU procurement rules.

Medicines management prescribing decision support technology is providing NHS organisations with the ability to make major savings by choosing cost-effective treatments.

The new framework agreement will also offer centralised and remote management of the profile of switch suggestions to deliver improved accuracy, visibility and consistency when prescribing. Linked with other systems, the technology makes suggestions and enables prescribers to switch easily to the suggested medicine, at an appropriate dose and frequency, if the switch suggestion is accepted.

The new framework for the technology is now open to organisations across the NHS, for further information please contact Caroline Wright on 0161 212 3721.

About NHS SBS
NHS Shared Business Services (NHS SBS) is the market leader in business support services for the NHS. It provides finance and accounting, employment services, procurement and primary care services, delivering operational efficiencies and improved service quality as well as real cost savings, on average 30%, for its NHS clients. Established in 2005, NHS SBS is a 50/50 joint venture between the Department of Health and Sopra Steria Limited. The organisation now provides financial services to 100% of all NHS commissioning organisations and a range of business support services for around 50% of NHS provider trusts.

NHS SBS currently employs over 1,750 people who bring a unique mix of NHS and commercial expertise. They process over £170 billion of NHS payments each year and pay 390,000 NHS employees. The organisation has also identified more than £350 million procurement savings opportunities. NHS SBS is on-course to achieve £1 billion of cost savings to the NHS by 2020, having achieved its original 10-year target of £224 million of cost savings, a year earlier than planned in 2014.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...